HM: Honoraria: BMS, Janssen, Abbvie, Pfizer, Forus, GSK, Sanofi, Amgen, Takeda. CPV: Honoraria: BMS, Janssen, Abbvie, Pfizer, Forus, GSK, Sanofi. RF: Consulting: AbbVie, Adaptive Biotechnologies, AMGEN, AZeneca, Bayer, Binding Site, BMS (Celgene), Millenium Takeda, Jansen, Juno, Kite, Merck, Pfizer, Pharmacyclics, Regeneron, Sanofi; Scientific Advisory Boards: Adaptive Biotechnologies, Caris Life Sciences, Oncotracker; Board of Directors: Antegene (for profit), AZBio (not for profit); patent for FISH in MM—~$2000/year.